SINGLETON J MATTHEW sold 37.5% of their position (5.70K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $397.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2024ACC: 0000950170-24-099980
Director
Since Jan 2019
-5.70K
Net shares
Net seller
$397.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.70K acquired · 11.40K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+5.70K
Price / share
$1.19
Trade value
$6.78K
% of position
60.0%
8/21/2024
9.50K→15.20K
Common Stock, par value $0.00001 per share
Direct
Shares
−5.70K
Price / share
$69.72
Trade value
$397.43K
% of position
37.5%
8/21/2024
15.20K→9.50K
Total
Net shares
+0.00
Net value
-$390.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 8/21/2024 | M · Option Exercise | +5.70K | $1.19 | $6.78K | 60.0% | 9.50K | 15.20K |
| Common Stock, par value $0.00001 per share Direct | 8/21/2024 | S · Sale | −5.70K | $69.72 | $397.43K | 37.5% | 15.20K | 9.50K |
| Total | +0.00 | -$390.65K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.70K shares
Shares
−5.70K
Strike price
1.19
Held after
10.30K
Exercisable
—
8/21/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.70K shares | 8/21/2024 | M · Option Exercise | −5.70K | 1.19 | — | 10.30K |